WHO ICTRP trial
Comparison of the effect of oxelidine and sufentanil equivalent dose in…
ChiCTR2400091785 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400091785 |
|---|---|
| Public title | Comparison of the effect of oxelidine and sufentanil equivalent dose in hysteroscopic surgery |
| Scientific title | Comparison of the effect of oxelidine and sufentanil equivalent analgesic dose in hysteroscopic surgery |
| Primary sponsor | Yancheng First People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Uterine lesion |
| Interventions | Oxeridine:Oxelidine 30ug/kg was administered intravenously 3min before operation, propofol 2mg/kg intravenously 1min before operation, and propofol 3-6 mg/(kg·h) was continuously injected intravenously during the… |
| Registration date | Nov 4, 2024 |
| Target size | Oxeridine:50;Sufentanil:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: